Stocks and Investing Stocks and Investing
Tue, February 2, 2016
Mon, February 1, 2016
Fri, January 29, 2016
Thu, January 28, 2016
Wed, January 27, 2016
Tue, January 26, 2016
Mon, January 25, 2016
Fri, January 22, 2016
Thu, January 21, 2016
Wed, January 20, 2016
Tue, January 19, 2016

Brian Abrahams Downgraded (SRPT) to Hold and Decreased Target to $15 on, Jan 19th, 2016


Published on 2024-10-25 11:05:49 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Downgraded "Sarepta Therapeutics, Inc." (SRPT) to Hold and Decreased Target from $62 to $15 on, Jan 19th, 2016.

Brian has made no other calls on SRPT in the last 4 months.



There is 1 other peer that has a rating on SRPT. Out of the 1 peers that are also analyzing SRPT, all agrees with Brian's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Joseph Schwartz of "Leerink Swann" Maintained at Hold with Decreased Target to $27 on, Friday, November 6th, 2015